FY2020 Earnings Estimate for HCA Healthcare Inc Issued By William Blair (HCA)

HCA Healthcare Inc (NYSE:HCA) – William Blair issued their FY2020 earnings per share estimates for HCA Healthcare in a research report issued on Wednesday, May 1st, Zacks Investment Research reports. William Blair analyst M. Larew forecasts that the company will post earnings per share of $11.12 for the year.

Several other research firms also recently issued reports on HCA. Barclays decreased their price objective on shares of HCA Healthcare from $155.00 to $145.00 and set an “overweight” rating for the company in a research note on Wednesday, April 17th. Raymond James upgraded shares of HCA Healthcare from a “market perform” rating to an “outperform” rating and boosted their price objective for the stock from $115.00 to $135.00 in a research note on Tuesday, April 23rd. Oppenheimer boosted their price objective on shares of HCA Healthcare from $142.00 to $150.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 30th. Zacks Investment Research downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating and set a $130.00 price objective for the company. in a research note on Monday. Finally, ValuEngine downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday, March 6th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and eighteen have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $149.00.

HCA stock traded up $0.71 on Monday, hitting $122.57. 1,044,800 shares of the company were exchanged, compared to its average volume of 1,808,120. HCA Healthcare has a twelve month low of $101.30 and a twelve month high of $147.42. The firm has a market capitalization of $42.12 billion, a price-to-earnings ratio of 12.55, a price-to-earnings-growth ratio of 0.99 and a beta of 0.75.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, April 30th. The company reported $2.97 EPS for the quarter, topping the consensus estimate of $2.31 by $0.66. HCA Healthcare had a net margin of 7.71% and a negative return on equity of 112.65%. The firm had revenue of $12.52 billion during the quarter, compared to analyst estimates of $12.34 billion. During the same quarter in the prior year, the business posted $3.18 earnings per share. HCA Healthcare’s revenue for the quarter was up 9.6% compared to the same quarter last year.

The company also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Monday, June 3rd will be paid a $0.40 dividend. The ex-dividend date of this dividend is Friday, May 31st. This represents a $1.60 annualized dividend and a dividend yield of 1.31%. HCA Healthcare’s dividend payout ratio (DPR) is presently 16.38%.

In other HCA Healthcare news, insider Jon M. Foster sold 44,281 shares of the stock in a transaction on Friday, May 10th. The shares were sold at an average price of $122.28, for a total transaction of $5,414,680.68. Following the transaction, the insider now directly owns 96,052 shares in the company, valued at approximately $11,745,238.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 2.70% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of HCA. Vanguard Group Inc raised its holdings in shares of HCA Healthcare by 0.3% during the third quarter. Vanguard Group Inc now owns 19,916,360 shares of the company’s stock worth $2,770,765,000 after purchasing an additional 66,808 shares during the period. Magellan Asset Management Ltd raised its holdings in shares of HCA Healthcare by 2.0% during the first quarter. Magellan Asset Management Ltd now owns 12,908,938 shares of the company’s stock worth $1,683,067,000 after purchasing an additional 258,477 shares during the period. Oregon Public Employees Retirement Fund raised its holdings in shares of HCA Healthcare by 16,494.3% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 11,119,359 shares of the company’s stock worth $89,000 after purchasing an additional 11,052,352 shares during the period. Geode Capital Management LLC raised its holdings in shares of HCA Healthcare by 7.9% during the first quarter. Geode Capital Management LLC now owns 3,683,434 shares of the company’s stock worth $479,397,000 after purchasing an additional 268,758 shares during the period. Finally, Northern Trust Corp raised its holdings in shares of HCA Healthcare by 9.4% during the fourth quarter. Northern Trust Corp now owns 3,579,428 shares of the company’s stock worth $445,459,000 after purchasing an additional 307,157 shares during the period. Hedge funds and other institutional investors own 70.30% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Story: How is the discount rate different from the Federal Funds rate?

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.